Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LCTX Lineage Cell Therapeutics Inc

交易中 07-22 15:06:41 EDT

1.02

+0.02

+1.50%

最高1.02	最低0.9952	成交量13.69万
今开0.9999	昨收1.00	日振幅2.48%
总市值1.92亿	流通市值1.49亿	总股本1.89亿
成交额13.77万	换手率0.09%	流通股本1.46亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LCTX","market":"US","secType":"STK","nameCN":"Lineage Cell Therapeutics Inc","latestPrice":1.015,"timestamp":1721675161117,"preClose":1,"halted":0,"volume":136872,"delay":0,"floatShares":146334917,"shares":188823975,"eps":-0.134517,"marketStatus":"交易中","marketStatusCode":2,"change":0.015,"latestTime":"07-22 15:06:41 EDT","open":0.9999,"high":1.02,"low":0.9952,"amount":137724.4798776,"amplitude":0.0248,"askPrice":1.02,"askSize":506,"bidPrice":1.01,"bidSize":1538,"shortable":3,"etf":0,"ttmEps":-0.134517,"exchange":"AMEX","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":699771600000,"adjPreClose":1,"preHourTrading":{"tag":"盘前","latestPrice":1.01,"preClose":1,"latestTime":"09:06 EDT","volume":102,"amount":103.0499982,"timestamp":1721653619062},"postHourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1,"latestTime":"18:49 EDT","volume":5960,"amount":6012.5,"timestamp":1721429355981},"volumeRatio":0.293705,"impliedVol":0.8848,"impliedVolPercentile":0.1315},"requestUrl":"/m/hq/s/LCTX","defaultTab":"news","newsList":[{"id":"2452625121","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速下挫5.14%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452625121","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452625121?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:13","pubTimestamp":1721232831,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时13分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速跳水5.14%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.09%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3176.54%、1361.14%、289.46%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为76.39%、46.25%、43.75%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180013529681db74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180013529681db74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2451191821","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘急速拉升5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451191821","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451191821?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:44","pubTimestamp":1721137483,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时44分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速拉升5.39%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1590.38%、684.24%、87.46%，振幅较大的相关个股有Aeon Biopharma, Inc.、Conduit Pharmaceuticals Inc.、Scisparc Ltd.，振幅分别为36.40%、34.67%、34.38%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162144449681d30e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162144449681d30e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4139"],"gpt_icon":0},{"id":"2450485088","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨6.10%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450485088","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450485088?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:25","pubTimestamp":1720628727,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时25分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨6.10%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Longeveron Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为3890.46%、1436.37%、1084.78%，振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.，振幅分别为421.88%、133.16%、119.83%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711002528af91a1db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711002528af91a1db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","LENZ"],"gpt_icon":0},{"id":"2449216868","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.28%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449216868","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449216868?lang=zh_cn&edition=full","pubTime":"2024-07-06 02:52","pubTimestamp":1720205537,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日02时52分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下挫5.28%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Mediwound Ltd.涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.较为活跃，换手率分别为20201.11%、2474.25%、134.75%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.，振幅分别为151.52%、102.68%、46.66%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706025218941f47d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706025218941f47d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","LENZ"],"gpt_icon":0},{"id":"2446430688","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌6.62%报0.962美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446430688","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446430688?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:34","pubTimestamp":1719581642,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时34分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速跳水6.62%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628213403941f24ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628213403941f24ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4139"],"gpt_icon":0},{"id":"2446372569","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.52%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446372569","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446372569?lang=zh_cn&edition=full","pubTime":"2024-06-28 01:49","pubTimestamp":1719510542,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日01时49分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速上涨5.52%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2824.85%、380.53%、349.94%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为322.04%、127.05%、81.43%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628014903aef6f463&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628014903aef6f463&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2446009271","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.03%报0.949美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446009271","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446009271?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:02","pubTimestamp":1719244933,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日00时02分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨5.03%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.84%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625000213968164a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625000213968164a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","LENZ"],"gpt_icon":0},{"id":"2445324910","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445324910","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445324910?lang=zh_cn&edition=full","pubTime":"2024-06-21 00:02","pubTimestamp":1718899357,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日00时02分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅跳水5.62%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621000237aef5ddb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621000237aef5ddb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2442084236","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442084236","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442084236?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:43","pubTimestamp":1718026995,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时43分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速下挫5.15%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214316af8cc4b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214316af8cc4b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2440412901","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘急速上涨5.00%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440412901","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440412901?lang=zh_cn&edition=full","pubTime":"2024-06-04 03:54","pubTimestamp":1717444466,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日03时54分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报1.05美元/股，成交量51.567万股，换手率0.27%，振幅7.70%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406040354269681193c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406040354269681193c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2439599509","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘急速下跌5.09%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439599509","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439599509?lang=zh_cn&edition=full","pubTime":"2024-05-30 02:04","pubTimestamp":1717005874,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日02时04分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.09%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。消息层面，截至02时04分，《Lineage Cell Therapeutics董事增持1万股普通股股份，价值约1.05万美元》资讯为影响Lineage Cell Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530020434968108f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530020434968108f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","LENZ"],"gpt_icon":0},{"id":"2439302009","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439302009","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439302009?lang=zh_cn&edition=full","pubTime":"2024-05-29 00:15","pubTimestamp":1716912901,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日00时15分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速跳水5.24%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.72%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。消息层面，截至00时15分，《Lineage Cell Therapeutics董事增持1万股普通股股份，价值约1.05万美元》资讯为影响Lineage Cell Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529001501aef21e9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529001501aef21e9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","LENZ"],"gpt_icon":0},{"id":"2437292205","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437292205","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437292205?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:48","pubTimestamp":1716389286,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时48分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.94%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Igm Biosciences, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Curevac N.V.涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为282.99%、142.01%、38.52%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts 、Oragenics Inc.，振幅分别为57.14%、48.75%、47.70%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522224807861ee5e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522224807861ee5e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LCTX"],"gpt_icon":0},{"id":"2436018143","title":"Lineage Cell Therapeutics, Inc.2024财年第一财季实现净利润-6.54百万美元，同比减少49.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436018143","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436018143?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:06","pubTimestamp":1716048362,"startTime":"0","endTime":"0","summary":"3月31日，Lineage Cell Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-6.54百万美元，同比减少49.66%；其中营业收入为1.44百万美元，同比减少39.75%，每股基本收益为-0.04美元。从资产负债表来看，Lineage Cell Therapeutics, Inc.总负债37.49百万美元，其中短期债务1.10百万美元，资产负债比为0.03，流动比率为2.71。机构评级：截至2024年3月31日，当前有5家机构对Lineage Cell Therapeutics, Inc.目标价做出预测，其中目标均价为5.20美元，其中最低目标价为4.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190006048b15e2f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190006048b15e2f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX"],"gpt_icon":0},{"id":"2435663376","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435663376","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435663376?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:02","pubTimestamp":1715608962,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时02分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速下挫5.13%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为50.70%、19.78%、18.82%，振幅较大的相关个股有Dbv Technologies、Tevogen Bio Holdings Inc.、Azitra Inc，振幅分别为36.84%、30.47%、29.77%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132202437a599bcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132202437a599bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2434870018","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨6.03%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434870018","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434870018?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:33","pubTimestamp":1715261638,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时33分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨6.03%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。该信息摘要如下：HC Wainwright & Co.：重申Lineage Cell Therapeutics评级，由买入调整至买入评级, 目标价7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092133587a59023d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092133587a59023d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","LENZ"],"gpt_icon":0},{"id":"2434877747","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434877747","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434877747?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:43","pubTimestamp":1715193831,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日02时43分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速跳水5.16%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。该信息摘要如下：HC Wainwright & Co.：重申Lineage Cell Therapeutics评级，由买入调整至买入评级, 目标价7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902435179268e5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902435179268e5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4139"],"gpt_icon":0},{"id":"2433648403","title":"HC Wainwright & Co.：重申Lineage Cell Therapeutics(LCTX.US)评级，由买入调整至买入评级, 目标价7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433648403","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433648403?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:45","pubTimestamp":1715006749,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Lineage Cell Therapeutics(LCTX.US)评级，由买入调整至买入评级, 目标价7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622455687d8c9ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622455687d8c9ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ"],"gpt_icon":0},{"id":"2433778174","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.66%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433778174","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433778174?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:27","pubTimestamp":1715005675,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时27分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅拉升5.66%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1025.35%、676.65%、57.58%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、84.25%、40.00%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622275587e85d6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622275587e85d6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2432420970","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432420970","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432420970?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:37","pubTimestamp":1714743430,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时37分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.71%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Vaxxinity, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为79.29%、23.62%、12.89%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.，振幅分别为26.55%、15.86%、15.78%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032137117925c0e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032137117925c0e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lineagecell.com","stockEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":0.1236},{"period":"3month","weight":-0.1304},{"period":"6month","weight":-0.0476},{"period":"1year","weight":-0.3243},{"period":"ytd","weight":-0.0826}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage Cell Therapeutics, Inc.于1990年在加利福尼亚州成立。该公司是一家临床阶段的生物技术公司，开发新的细胞疗法，以解决未得到满足的医疗需求。该公司的项目基于专有的基于细胞的技术平台以及相关的开发和制造能力。在这个平台上，该公司设计、开发、制造和测试具有与人体自然细胞相似或相同的解剖学和生理功能的专门人体细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.069381},{"month":2,"riseRate":0.294118,"avgChangeRate":-0.036986},{"month":3,"riseRate":0.705882,"avgChangeRate":0.072614},{"month":4,"riseRate":0.294118,"avgChangeRate":-0.076478},{"month":5,"riseRate":0.411765,"avgChangeRate":-0.045447},{"month":6,"riseRate":0.411765,"avgChangeRate":0.010105},{"month":7,"riseRate":0.294118,"avgChangeRate":-0.034108},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.036742},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.00358},{"month":10,"riseRate":0.4375,"avgChangeRate":0.703635},{"month":11,"riseRate":0.4375,"avgChangeRate":0.021643},{"month":12,"riseRate":0.625,"avgChangeRate":0.029638}],"exchange":"AMEX","name":"Lineage Cell Therapeutics Inc","nameEN":"Lineage Cell Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage Cell Therapeutics Inc,LCTX,Lineage Cell Therapeutics Inc股票,Lineage Cell Therapeutics Inc股票老虎,Lineage Cell Therapeutics Inc股票老虎国际,Lineage Cell Therapeutics Inc行情,Lineage Cell Therapeutics Inc股票行情,Lineage Cell Therapeutics Inc股价,Lineage Cell Therapeutics Inc股市,Lineage Cell Therapeutics Inc股票价格,Lineage Cell Therapeutics Inc股票交易,Lineage Cell Therapeutics Inc股票购买,Lineage Cell Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}